FDA Inspection
Texas Fertility CenterTexas Fertility Center – FDA Inspection, Jun 21, 2023
Record Details
This FDA Inspection record concerns Texas Fertility Center, with an inspection on June 21, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · c84e051c-f2b3-4ddb-8e87-da50c9fd477c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1208499
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 1271.75(a)(1)Risk factors, clinical evidence
- 21 CFR 1271.75(a)(1)Risk factors, clinical evidence
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Texas Fertility Center
3| Date | Classification | Office | Project area |
|---|---|---|---|
| March 25, 2026 | Not classified | Dallas District Office | Human Cellular, Tissue, and Gene Therapies |
| May 31, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 6, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Texas Fertility Center
- FDA Inspection 1309516 - 2026-03-25
- FDA Inspection 1057442 - 2018-05-31
- FDA Inspection 899042 - 2014-10-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.